Data integrity of 35 randomised controlled trials in women' health.
Data integrity
Fabricated data
Ovulation induction
Randomization
Research integrity
Journal
European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
16
03
2020
revised:
27
03
2020
accepted:
02
04
2020
pubmed:
10
5
2020
medline:
6
3
2021
entrez:
9
5
2020
Statut:
ppublish
Résumé
While updating a systematic review on the topic of ovulation of induction, we observed unusual similarities in a number of randomised controlled trials (RCTs) published by two authors from the same institute in the same disease spectrum in a short period of time. We therefore undertook a focused analysis of the data integrity of all RCTs published by the two authors. We made pairwise comparisons to find identical or similar values in baseline characteristics and outcome tables between trials. We also assessed whether baseline characteristics were compatible with chance, using Monte Carlo simulations and Kolmogorov-Smirnov test. For 35 trials published between September 2006 and January 2016, we found a large number of similarities in both the baseline characteristics and outcomes of 26. Analysis of the baseline characteristics of the trials indicated that their distribution was unlikely to be the result of proper randomisation. The procedures demonstrated in this paper may help to assess data integrity in future attempts to verify the authenticity of published RCTs.
Identifiants
pubmed: 32381348
pii: S0301-2115(20)30184-6
doi: 10.1016/j.ejogrb.2020.04.016
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
72-83Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest LMA is a co-convener of the Cochrane Prospective Meta-analysis Methods Group and manager of the Australian New Zealand Clinical Trials Registry. MvW is co-oordinating editor of the Netherlands Satellite of the Cochrane Gynaecology and Fertiliy Group. BWM reports grants from NHMRC, personal fees from ObsEva, personal fees from Merck Merck KGaA, personal fees from Guerbet, personal fees from iGenomix, outside the submitted work. All other authors have no conflicts of interest.